These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 5996243

  • 21. The effect of drugs on uptake and release of catecholamines in the isolated left atrium of the guinea pig.
    Cervoni P, Kirpekar SM, Schwab A.
    J Pharmacol Exp Ther; 1966 Feb; 151(2):196-206. PubMed ID: 5932598
    [No Abstract] [Full Text] [Related]

  • 22. The influence of sympathomimetic amines, monoamine oxidase inhibitors, and antihypertensives upon the energy metabolism in the rat heart.
    Hilliard WG, Oliver WT, Van Petten GR.
    Can J Physiol Pharmacol; 1966 Jul; 44(4):605-13. PubMed ID: 5968213
    [No Abstract] [Full Text] [Related]

  • 23. Cardiovascular effects of pyrogallol and 4-tropoloneacetamide.
    Glavas E, Trajkov T, Nikodijeviç B.
    Arch Int Pharmacodyn Ther; 1967 Nov; 170(1):134-7. PubMed ID: 4383321
    [No Abstract] [Full Text] [Related]

  • 24. Reversal by amphetamine of the protective effect of bretylium on reserpine-induced depletion of noradrenaline.
    Chang CC.
    J Pharm Pharmacol; 1965 Dec; 17(12):818-20. PubMed ID: 4379763
    [No Abstract] [Full Text] [Related]

  • 25. Effect of reserpine and some adrenolytics on the anticoagulant activity of pelentan (ethylbiscoumacetate).
    Hrdina P, Kovalcík V.
    Thromb Diath Haemorrh; 1967 Dec 31; 18(3-4):759-65. PubMed ID: 5590255
    [No Abstract] [Full Text] [Related]

  • 26. Electrophysiologic effects of bretylium tosylate on single fibers of the canine specialized conducting system and ventricle.
    Wit AL, Steiner C, Damato AN.
    J Pharmacol Exp Ther; 1970 Jun 31; 173(2):344-56. PubMed ID: 4393574
    [No Abstract] [Full Text] [Related]

  • 27. [Drugs with effect on the adrenergic nerve fiber].
    Haefely W.
    Pharm Acta Helv; 1968 Dec 31; 43(12):757-75. PubMed ID: 4886667
    [No Abstract] [Full Text] [Related]

  • 28. Interactions of bretylium and other drugs on guinea-pig atria: evidence for inhibition of neuronal monoamine oxidase by bretylium.
    Furchgott RF, Garcia PS, Wakade AR, Cervoni P.
    J Pharmacol Exp Ther; 1971 Nov 31; 179(2):171-85. PubMed ID: 4399958
    [No Abstract] [Full Text] [Related]

  • 29. Mechanism of the positive inotropic responses to bretylium and guanethidine.
    BHAGAT B, SHIDEMAN FE.
    Br J Pharmacol Chemother; 1963 Feb 31; 20(1):56-62. PubMed ID: 13967966
    [Abstract] [Full Text] [Related]

  • 30. Modification of vasodepressor responses to adrenaline by drugs.
    Rajapurkar MV, Sharma ML, Dashputra PG, Jayaswal CL.
    Arch Int Pharmacodyn Ther; 1965 Apr 31; 154(2):283-9. PubMed ID: 4378731
    [No Abstract] [Full Text] [Related]

  • 31. Cocaine and antihistaminic compounds: comparison of effects of some cardiovascular actions of norepinephrine, tyramine and bretylium.
    Johnson GL, Kahn JB.
    J Pharmacol Exp Ther; 1966 Jun 31; 152(3):458-68. PubMed ID: 4380726
    [No Abstract] [Full Text] [Related]

  • 32. Tyramine-induced modifications of ventricular fibrillation thresholds in the dog: influence of sympatholytic agents.
    Wellens D, Wauters E.
    Arch Int Pharmacodyn Ther; 1973 Feb 31; 201(2):253-61. PubMed ID: 4125092
    [No Abstract] [Full Text] [Related]

  • 33. [Pharmacologic inhibition of the mobilization of free fatty acids].
    Bert F, Paoletti R.
    Rev Atheroscler (Paris); 1968 Feb 31; 10(1):31-42. PubMed ID: 4386492
    [No Abstract] [Full Text] [Related]

  • 34. 5-HT autopotentiation and drug induced changes in the 5-HT vasomotor response in the pithed rat.
    Leach GD, Fozard JR.
    Eur J Pharmacol; 1969 Jul 31; 7(1):14-22. PubMed ID: 4390381
    [No Abstract] [Full Text] [Related]

  • 35. Histochemical studies on the release of the adrenergic transmitter by nerve impulses in combination with drugs, especially adrenergic neuron blocking agents.
    Malmfors T.
    Pharmacology; 1969 Jul 31; 2(3):138-50. PubMed ID: 4310294
    [No Abstract] [Full Text] [Related]

  • 36. [Studies on the role of sympathetic transmitter substances for renal autoregulation].
    Baumgarten HG, Leichtweiss HP, Weiss C.
    Pflugers Arch Gesamte Physiol Menschen Tiere; 1968 Jul 31; 299(3):214-25. PubMed ID: 4385654
    [No Abstract] [Full Text] [Related]

  • 37. Modification by AZ-55, guanethidine and bretylium of responses of atria and aortic strips to transmural stimulation.
    Toda N, Usui H, Shimamoto K.
    Jpn J Pharmacol; 1972 Feb 31; 22(1):125-35. PubMed ID: 4537620
    [No Abstract] [Full Text] [Related]

  • 38. Peripheral noradrenaline and adrenergic transmission in the rat.
    Spriggs TL.
    Br J Pharmacol Chemother; 1966 Jan 31; 26(1):271-81. PubMed ID: 5919511
    [No Abstract] [Full Text] [Related]

  • 39. Mitochondrial lesions of developing sympathetic neurons induced by bretylium tosylate.
    Caramia F, Ubaldo Angeletti P, Levi-Montalcini R, Carratelli L.
    Brain Res; 1972 May 26; 40(2):237-46. PubMed ID: 5027164
    [No Abstract] [Full Text] [Related]

  • 40. The human platelet as a pharmacologic model for the adrenergic neuron. The uptake and release of norepinephrine.
    Abrams WB, Solomon HM.
    Clin Pharmacol Ther; 1969 May 26; 10(5):702-9. PubMed ID: 4390109
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.